SCHEMBL8036155

SCHEMBL8036155

COc1cc(Cl)c(C(=O)NC(=O)NCC2CC2)c([N+](=O)[O-])c1O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
HTR4 Q13639 2/20 0.39
TDP1 Q9NUW8 1/20 0.37
DRD2 P14416 3/20 0.37
DRD3 P35462 2/20 0.37
TP53 P04637 2/20 0.36
ALPL P05186 1/20 0.36
ALPI P09923 1/20 0.36
ALPG P10696 1/20 0.36
G6PD P11413 1/20 0.36
CRHBP P24387 1/20 0.36
CRHR2 Q13324 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2D6 P10635 1/20 0.36
MAPK1 P28482 1/20 0.36
ATG4B Q9Y4P1 1/20 0.35
PYGL P06737 1/20 0.35
PMP22 Q01453 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8035190 0.86 POLB (0.39) MEN1KMT2ACYP3A4ATG4B
SCHEMBL8022533 0.84 G6PD (0.38) MEN1KMT2AG6PDCRHBPCRHR2
SCHEMBL8035129 0.84 ALDH1A1 (0.39) MEN1KMT2AHTR4PYGL
SCHEMBL8028329 0.82 G6PD (0.37) MEN1KMT2ATDP1G6PDCRHBP
SCHEMBL8038459 0.82 TRPV1 (0.39) G6PDCRHBPCRHR2
SCHEMBL8032230 0.80 MAPT (0.38) MEN1KMT2ATDP1G6PDCRHBP
SCHEMBL3467921 0.78 POLB (0.42) MEN1KMT2ADRD2DRD3TP53
SCHEMBL8025556 0.75 NPSR1 (0.42) MEN1KMT2ATDP1G6PDCRHBP
SCHEMBL8025557 0.73 FAAH (0.36) MEN1KMT2AG6PDCRHBPCRHR2
SCHEMBL8044942 0.71 TDP1 (0.38) TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009081892-A1 NOVEL CATECHOL DERIVATIVE, PHARMACEUTICAL COMPOSITION CONTAINING THE SAME, AND USE OF THOSE KISSEI PHARMACEUTICAL CO., LTD. (JP) 2009-07-02 WO disclosed